Literature DB >> 8599738

Merkel cell carcinoma.

W J O'Connor1, D G Brodland.   

Abstract

BACKGROUND: Merkel cell carcinoma is an aggressive tumor with nonspecific clinical features. The prognosis in general is worse than malignant melanoma. Local recurrence rates are high with one-third of patients having recurrence within one year of excision. The tumor invades blood vessels and lymphatics. This frequent lymphatic dissemination leads later to satellite lesions and recurrence. Distant metastases occur in one-third of patients. One-,two- and three-year survival rates are poor, being estimated at 88%, 72%, and 55%, respectively.
OBJECTIVE: To increase awareness of the behavior of this uncommon tumor.
METHODS: A review of the current literature and recommendations regarding this tumor.
RESULTS: Wide local excision with 3-cm margin shows significant reduction in local recurrence compared with 2-cm margins. Two-thirds of patients with local recurrence ultimately die from their disease. Radiation therapy has a role to play in the local and regional clearance of the tumor.
CONCLUSION: Prompt diagnosis and surgical excision are necessary to improve survival. Mohs micrographic surgery offers potential advantages in evaluating both the lateral and the deep margins. Follow-up studies of patients treated with this modality will be beneficial.

Entities:  

Mesh:

Year:  1996        PMID: 8599738     DOI: 10.1111/j.1524-4725.1996.tb00317.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  10 in total

Review 1.  Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature.

Authors:  Sofiane Maza; Uwe Trefzer; Maja Hofmann; Silke Schneider; Christiane Voit; Thomas Krössin; Andreas Zander; Heike Audring; Wolfram Sterry; Dieter L Munz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-24       Impact factor: 9.236

Review 2.  Merkel cell carcinoma.

Authors:  Emma Ramahi; Jehee Choi; Clifton D Fuller; Tony Y Eng
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

Review 3.  Merkel cell carcinoma of the forehead area: a literature review and case report.

Authors:  Claudio Caldarelli; Umberto Autorino; Caterina Iaquinta; Andrea De Marchi
Journal:  Oral Maxillofac Surg       Date:  2019-07-24

Review 4.  Merkel cell carcinoma of the breast: report of a case and review of the literature.

Authors:  L Cusick; S E Refsum
Journal:  Ulster Med J       Date:  2004-11

5.  Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck.

Authors:  Seesha R Takagishi; Tessa E Marx; Christopher Lewis; Erica S Tarabadkar; Ilsa D Juhlin; Astrid Blom; Jayasri G Iyer; Jay J Liao; Yolanda D Tseng; Teresa Fu; Paul Nghiem; Upendra Parvathaneni
Journal:  Adv Radiat Oncol       Date:  2016-10-20

6.  Computed tomography accelerates staging in patients with Merkel cell carcinoma.

Authors:  Elisabeth Foki; Alexandra Fochtmann-Frana; Georg Haymerle; Stefan Nemec; Benjamin Loader; Christos Perisanidis; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-28       Impact factor: 2.503

7.  Imaging in patients with merkel cell carcinoma.

Authors:  Elisabeth Enzenhofer; Philipp Ubl; Christian Czerny; Boban M Erovic
Journal:  J Skin Cancer       Date:  2013-02-06

Review 8.  Merkel cell carcinoma.

Authors:  Michael S Lehrer; Diane Hershock; Michael E Ming
Journal:  Curr Treat Options Oncol       Date:  2004-06

9.  Merkel cell carcinoma.

Authors:  Virve Koljonen
Journal:  World J Surg Oncol       Date:  2006-02-08       Impact factor: 2.754

Review 10.  Merkel Cell Carcinoma: New Trends.

Authors:  Ellen M Zwijnenburg; Satish F K Lubeek; Johanna E M Werner; Avital L Amir; Willem L J Weijs; Robert P Takes; Sjoert A H Pegge; Carla M L van Herpen; Gosse J Adema; Johannes H A M Kaanders
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.